Engineered immunostimulatory H 2 O 2 ‐producing microreactors driven by yeast as localized living cancer therapeutics
The development of locoregional cancer therapeutics capable of achieving tumor‐selective cytotoxicity while simultaneously eliciting systemic antitumor immunity remains an urgent clinical need. Herein, we present a hypoxia‐responsive living microreactor (designated as SACP) fabricated through co‐encapsulation of S...